Healthcare & Life Science M&A Activity Plummets 1H’22
HIT Consultant
AUGUST 5, 2022
Health Service Equities and Big Pharma: Healthcare Service equities underperformed the S&P 500, but the outperformance of the Big Pharma and Biotech sub-sectors allowed healthcare overall to keep pace with the market. Hospital stocks dropped 32.6% in Q2 2022, with only Acadia Healthcare posting a gain in share price.
98 
Let's personalize your content